BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 29, Issue 35
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (4959)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.
Item 
Count 
PDF115
WORD46
HTML2117
Figures (1-5)428
Tables (1-1)382
 Sum=3088
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse219
Download665
 Sum=884
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse226
Download590
 Sum=816
Sep 21, 2023 (publication date) through Apr 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Yu HS, Jiang H, Li MK, Yang BL, Smayi A, Chen JN, Wu B, Yang YD. Lowering the threshold of alanine aminotransferase for enhanced identification of significant hepatic injury in chronic hepatitis B patients. World J Gastroenterol 2023; 29(35): 5166-5177 [PMID: 37744292 DOI: 10.3748/wjg.v29.i35.5166]
URL: https://www.wjgnet.com/1007-9327/full/v29/i35/5166.htm
Number Citing Articles
1
Xue-Yan Yang, Xi-Dong Li, Bai-Yun Wu, Qiao Yang, Yu-Bao Zheng, Ming-Hua Zheng, Yin-Ping Wu, Hang-Yu Ma, Jing Zuo, Ruo-Xi Jia, Yue Yu, Ling-Yun Xu, Yu-Xin Tian, Qi An, Tao Zhang, Ying-Li He, Yu Shi, Yu-Chen Fan. A Model to Identify Gray Zone Patients With Chronic Hepatitis B Requiring Antiviral Therapy: A Multicenter Retrospective Study. The Journal of Infectious Diseases 2025;  doi: 10.1093/infdis/jiaf070
2
Zi-Hong Bao, Zhi-Kun Dai, Hao-Xian Tang. Antiviral treatment standards for hepatitis B: An urgent need for expansion. World Journal of Gastroenterology 2024; 30(4): 418-420 doi: 10.3748/wjg.v30.i4.418
3
Yen-Chun Liu, Wen-Juei Jeng. Should Indications for Antiviral Therapy for Hepatitis B Be Broadened to Include Immune-Tolerant Patients, Inactive Carriers, or Patients in the “Gray Zone”?. Current Hepatology Reports 2024; 23(1): 11 doi: 10.1007/s11901-024-00635-w
4
Hao Jiang, Hongsheng Yu, Yinan Huang, Mingkai Li, Bilan Yang, Xiaoli Xi, Yiming Lei, Bin Wu, Yidong Yang. Natural History and Prognosis of Chronic Hepatitis B Patients in the Indeterminate Phase. Journal of Gastroenterology and Hepatology 2025; 40(3): 720 doi: 10.1111/jgh.16849
5
Yuhua Gao, Mingyang Wang, Xia’nan Liu, Benjamin M. Liu. Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase. Microbiology Spectrum 2024; 12(4) doi: 10.1128/spectrum.03941-23
6
Hongsheng Yu, Yinan Huang, Mingkai Li, Hao Jiang, Bilan Yang, Xiaoli Xi, Abdukyamu Smayi, Bin Wu, Yidong Yang. Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver disease. Journal of Gastroenterology and Hepatology 2024; 39(10): 2169 doi: 10.1111/jgh.16673
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345